Shaden Kamhawi Selected Research

Salivary Proteins and Peptides

12/2022	Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial.
11/2022	A Composite Recombinant Salivary Proteins Biomarker for Phlebotomus argentipes Provides a Surveillance Tool Postelimination of Visceral Leishmaniasis in India.
12/2020	Implicating bites from a leishmaniasis sand fly vector in the loss of tolerance in pemphigus.
1/2020	Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
1/2020	Phlebotomus papatasi sand fly predicted salivary protein diversity and immune response potential based on in silico prediction in Egypt and Jordan populations.
1/2020	Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates.
1/2019	DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica.
12/2018	The PAGODAS protocol: pediatric assessment group of dengue and Aedes saliva protocol to investigate vector-borne determinants of Aedes-transmitted arboviral infections in Cambodia.
1/2018	Mosquito Saliva: The Hope for a Universal Arbovirus Vaccine?
1/2018	Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaden Kamhawi Research Topics

Disease

23	Leishmaniasis 11/2023 - 09/2006
22	Bites and Stings (Sting) 01/2024 - 05/2007
19	Infections 11/2023 - 05/2007
17	Visceral Leishmaniasis (Kala Azar) 11/2023 - 03/2006
10	Cutaneous Leishmaniasis 11/2023 - 10/2004
4	Vector Borne Diseases 01/2020 - 01/2006
3	Malaria 06/2018 - 05/2007
3	Hypersensitivity (Allergy) 01/2018 - 01/2006
2	Neglected Diseases 11/2023 - 01/2011
2	Pemphigus (Pemphigus Vulgaris) 01/2023 - 12/2020
2	Pain (Aches) 12/2022 - 01/2020
2	Mosquito-Borne Diseases 12/2022 - 01/2020
2	Coinfection 01/2021 - 01/2018
2	Inflammation (Inflammations) 10/2020 - 01/2016
2	Echinococcosis (Hydatid Cysts) 12/2012 - 01/2011
1	Edema (Dropsy) 01/2023
1	Immune System Diseases (Immune Disorders) 01/2023
1	Pruritus (Itching) 01/2020
1	Exanthema (Rash) 01/2020
1	Erythema 01/2020
1	Dengue (Dengue Fever) 12/2018
1	Filariasis 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Latent Infection 01/2017
1	Ulcer 12/2012
1	Chagas Disease (American Trypanosomiasis) 09/2012
1	Cardiomyopathies (Cardiomyopathy) 09/2012
1	Cysticercosis 01/2011
1	Parasitic Diseases (Parasitic Disease) 06/2008

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 11/2023 - 09/2006
25	Salivary Proteins and PeptidesIBA 12/2022 - 01/2006
11	AntigensIBA 11/2023 - 05/2007
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2006
6	CytokinesIBA 01/2021 - 06/2009
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
4	leishmaninIBA 11/2023 - 12/2009
4	Leishmaniasis VaccinesIBA 01/2021 - 05/2009
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 03/2008
3	ChemokinesIBA 01/2021 - 04/2014
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2022 - 01/2021
2	Combined VaccinesIBA 10/2021 - 11/2017
2	glucopyranosyl lipid-AIBA 10/2021 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	AntibodiesIBA 12/2020 - 01/2015
2	Heme Oxygenase-1IBA 10/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2016
2	Recombinant ProteinsIBA 11/2017 - 12/2012
2	Interleukin-12 (IL 12)IBA 05/2009 - 05/2007
1	Hematoxylin (Haematoxylon)IBA 01/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2024
1	Tryptases (Tryptase)IBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	CarrageenanIBA 01/2023
1	VirosomesIBA 10/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	AutoantigensIBA 12/2020
1	DesmogleinsIBA 12/2020
1	Heme (Haem)IBA 10/2020
1	IronIBA 10/2020
1	IsoenzymesIBA 10/2020
1	miltefosine (Impavido)IBA 12/2019
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 12/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	InflammasomesIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Interleukin-7 (Interleukin 7)IBA 01/2018
1	Apyrase (ATP Diphosphatase)IBA 01/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	Subunit VaccinesIBA 01/2017
1	EmulsionsIBA 01/2017
1	Cysteine Proteases (Cysteine Protease)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 11/2015
1	DNA VaccinesIBA 04/2014
1	Peptides (Polypeptides)IBA 04/2014
1	amsonic acid (DAS)IBA 04/2014
1	EpitopesIBA 04/2014
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 12/2012
1	Attenuated VaccinesIBA 07/2010
1	Interleukin-4 (Interleukin 4)IBA 04/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2007
1	Interferon-gamma (Interferon, gamma)IBA 05/2007
1	Galectins (Galectin)IBA 10/2004

Therapy/Procedure

1	Intradermal Injections 01/2021
1	Subcutaneous Injections 01/2020
1	Insecticide-Treated Bednets 06/2018
1	Injections 09/2012
1	Drug Therapy (Chemotherapy) 09/2012